LEAP2 - liver enriched antimicrobial peptide 2 Gene

Also Known as LEAP-2

生物種: Homo sapiens

遺伝子タイプ: protein coding
遺伝子ID: 116842

About LEAP2

Cytogenetic location: 5q31.1 Genomic coordinates (GRCh38): 5:132,873,668-132,875,046 (from NCBI)

This gene has 3 transcripts (splice variants) and 116 orthologues. Biased expression in liver (RPKM 158.3), small intestine (RPKM 13.5) and 1 other tissue.

Summary

This gene encodes a cysteine-rich cationic antimicrobial peptide that is expressed predominantly in the liver. The mature peptide has activity against gram-positive bacteria and yeasts. [provided by RefSeq, Sep 2014]

LEAP2 Products (1)

mRNA Protein Name
NM_052971.3 NP_443203.1 liver-expressed antimicrobial peptide 2 precursor

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence 参考文献 由来
involved in antimicrobial humoral immune response mediated by antimicrobial peptide IMP
IMP: Inferred from mutant phenotype
12493837 GOA
involved in defense response to fungus IMP
IMP: Inferred from mutant phenotype
12493837 GOA
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern

LEAP2 Protein Structure

LEAP-2

LEAP-2: Liver-expressed antimicrobial peptide 2 precursor (LEAP-2) (1 - 77)

  • 0
  • 77 a.a.
Protein Preferred Names Protein Names

liver-expressed antimicrobial peptide 2

関連疾患

Diseases Alias
Listeria Meningitis

  • Meningitis, Listeria
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

  • Clinical Phase
  • Pre-clinical Phase

Clinical Phase

Bioactive Molecules (1)
製品番号 製品名 製品効果
純度 Phase
HY-P5645 LEAP-2 98.55% Phase 2

Pre-clinical Phase

Bioactive Molecules (1)
製品番号 製品名
製品効果
純度
Rare Diseases
HY-RS07582 LEAP2 Human Pre-designed siRNA Set A Pre-designed Set / Unkown

Orthologs Information

生物種 Symbol 由来 ID
Rattus norvegicus LEAP2 RGD RGD:1561235
Mus musculus LEAP2 MGD MGI:2672795
Canis familiaris LEAP2 VGNC VGNC:42628
Felis catus LEAP2 VGNC VGNC:102242
Bos taurus LEAP2 VGNC VGNC:30831
Macaca mulatta LEAP2 VGNC VGNC:74161
Others LEAP2 NCBI